- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 277/26 - Radicals substituted by sulfur atoms
Patent holdings for IPC class C07D 277/26
Total number of patents in this class: 96
10-year publication summary
6
|
5
|
9
|
4
|
11
|
5
|
9
|
9
|
3
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Red Bull GmbH | 880 |
8 |
Bayer Pharma AG | 1096 |
4 |
Dow AgroSciences LLC | 1267 |
4 |
Enanta Pharmaceuticals, Inc. | 420 |
4 |
Sanford Burnham Prebys Medical Discovery Institute | 257 |
4 |
Merck Sharp & Dohme LLC | 3689 |
4 |
Avexxin AS | 50 |
3 |
The Institute of Cancer Research: Royal Cancer Hospital | 186 |
3 |
Kumiai Chemical Industry Co., Ltd. | 307 |
3 |
BASF SE | 19740 |
2 |
GlycoFi, Inc. | 34 |
2 |
Kancera AB | 31 |
2 |
Mitsubishi Tanabe Pharma Corporation | 579 |
2 |
Oregon Health & Science University | 746 |
2 |
Seoul National University Industry Foundation | 405 |
2 |
Shin Nippon Biomedical Laboratories, Ltd. | 84 |
2 |
Universite de droit et de La Sante de Lille 2 | 44 |
2 |
Paris Sciences et Lettres - Quartier Latin | 170 |
2 |
Migal Galilee Research Institute Ltd. | 48 |
2 |
Corteva Agriscience LLC | 2494 |
2 |
Other owners | 37 |